Budapest, Hungary

András Málnási-Csizmadia


 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: András Málnási-Csizmadia: Innovator in Pharmaceutical Compounds

Introduction

András Málnási-Csizmadia is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that selectively inhibit myosin 2 isoforms. With a total of 3 patents to his name, Málnási-Csizmadia's work is recognized for its potential impact on medical treatments.

Latest Patents

His latest patents include innovative compounds that are pharmaceutically effective in inhibiting selectively the myosin 2 isoforms. The inventions relate to compounds of specific formulas, including pharmaceutically acceptable salts, solvates, tautomers, and stereoisomers, which encompass enantiomers, diastereomers, and racemic mixtures. These compounds hold promise for various pharmaceutical applications.

Career Highlights

Throughout his career, András Málnási-Csizmadia has worked with esteemed institutions such as Eötvös Loránd University and Printnet Kereskedelmi és Szolgáltató Kft. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

He has collaborated with notable colleagues, including András Szabó and Péter Hári, which has further enriched his research endeavors and innovation processes.

Conclusion

András Málnási-Csizmadia stands out as a significant figure in the pharmaceutical industry, with his innovative patents paving the way for advancements in medical treatments. His contributions reflect a commitment to enhancing healthcare through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…